Douglas Schuling - Signal Genetics Independent Director
Director
Mr. Douglas A. Schuling. Mr. Schuling became a member of the board of SIGNAL GENETICS, INC. immediately prior to the listing of the Common Stock on The NASDAQ Capital Market in June 2014. From April 1999 through May 2011, when he retired, Mr. Schuling held the position of Executive Vice President and Chief Financial Officer for Genoptix, Inc., a publicly traded specialized laboratory service provider focused on delivering diagnostic services to hematologists and oncologists. Since May 2011, Mr. Schuling has acted as an independent consultant. From 1997 to March 1999, Mr. Schuling held the position of Chief Financial and Operating Officer for PointofCare Systems, a VC backed clinical information systems company. From 1985 to 1997, Mr. Schuling held various positions at Nellcor Puritan Bennett, a research, development and manufacturing company, specializing in medical equipment and supplies, most recently as Hospital Group Controller. Mr. Schuling received his B.S. degree in accounting from Drake University
| Age | 53 |
| Phone | 760-537-4100 |
| Web | http://www.signalgenetics.com |
Signal Genetics Management Efficiency
The company has return on total asset (ROA) of (0.56) % which means that it has lost $0.56 on every $100 spent on assets. This is way below average. Signal Genetics' management efficiency ratios could be used to measure how well Signal Genetics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 1.1 M in liabilities with Debt to Equity (D/E) ratio of 0.24, which may suggest the company is not taking enough advantage from borrowing. Signal Genetics has a current ratio of 2.23, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Signal Genetics until it has trouble settling it off, either with new capital or with free cash flow. So, Signal Genetics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Signal Genetics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Signal to invest in growth at high rates of return. When we think about Signal Genetics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Vijay Raghavan | Relx PLC ADR | N/A | |
| Terence Harvey | Perseus Mining Limited | N/A | |
| Linda Sanford | Relx PLC ADR | 68 | |
| SallyAnne Layman | Perseus Mining Limited | N/A | |
| Colin Carson | Perseus Mining Limited | N/A | |
| Wolfhart Hauser | Relx PLC ADR | 71 | |
| Stephen Appel | Visionary Education Technology | 64 | |
| Suzanne Wood | Relx PLC ADR | 60 | |
| Harvey Eads | Visionary Education Technology | 73 | |
| John Fazzini | Visionary Education Technology | 75 | |
| Xing Liu | 51Talk Online Education | 47 | |
| Carol Mills | Relx PLC ADR | 63 | |
| Marike Lels | Relx PLC ADR | 61 | |
| Robert MacLeod | Relx PLC ADR | 56 | |
| John McGloin | Perseus Mining Limited | N/A | |
| Lisa Hook | Relx PLC ADR | 57 | |
| Xiaoguang Wu | 51Talk Online Education | 45 | |
| Matthew Scully | Perseus Mining Limited | N/A | |
| Alexander Davidson | Perseus Mining Limited | N/A | |
| Wei Li | 51Talk Online Education | 41 | |
| Michael Bohm | Perseus Mining Limited | N/A | |
Management Performance
| Return On Asset | -0.56 |
Signal Genetics Leadership Team
Elected by the shareholders, the Signal Genetics' board of directors comprises two types of representatives: Signal Genetics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Signal. The board's role is to monitor Signal Genetics' management team and ensure that shareholders' interests are well served. Signal Genetics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Signal Genetics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sudipto Sur, CIO | ||
| Douglas Schuling, Independent Director | ||
| David Gonyer, Independent Director | ||
| Bennett LeBow, Chairman of the Board | ||
| Samuel Riccitelli, CEO and President and Director | ||
| Robin Smith, Independent Director | ||
| Tamara Seymour, CFO | ||
| Richard Bender, Chief Medical Officer |
Signal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Signal Genetics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.56 | |||
| Profit Margin | (2.73) % | |||
| Operating Margin | (3.08) % | |||
| Current Valuation | (3.06 M) | |||
| Shares Outstanding | 8.09 M | |||
| Shares Owned By Insiders | 48.36 % | |||
| Shares Owned By Institutions | 7.20 % | |||
| Number Of Shares Shorted | 21.29 K | |||
| Price To Earning | 52.75 X | |||
| Price To Book | 0.75 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Signal Stock
If you are still planning to invest in Signal Genetics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Signal Genetics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |